Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Diseases 1Neoplasms by Site 1Neoplasms 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Digestive System Neoplasms 1Digestive System Diseases 1Colorectal Neoplasms 1Colonic Diseases 1

Interventions

Sunitinib 2Irinotecan 2Ascorbic Acid 2spartalizumab 1linifanib 1genexol-PM 1dostarlimab 1alectinib 1Sorafenib 1Ramucirumab 1NUC-1031 1Methods 1Meditation 1KRN-330 1Gemcitabine 1Flucytosine 1Everolimus 1Educational Status 1Early Intervention, Educational 1Cisplatin 1Body Height 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Digestive System Neoplasms × KRN-330 × Clear all
NCT00838578 2024-04-26

Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

Kyowa Kirin Co., Ltd.

Phase 1/2 Terminated
65 enrolled 7 charts
Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡